Literature DB >> 2157559

Factors influencing local recurrence of cancer after partial mastectomy.

G Crile1, C B Esselstyn.   

Abstract

From 1957 to 1975, 291 patients underwent partial mastectomy for carcinoma of the breast. In a follow-up period of 6 to 25 years, 32 patients had local recurrences. These 32 were matched with 32 patients without local recurrence but who had had the same treatment during the same periods of time for the same clinical stage of disease. Comparisons were made for age of the patient, family history, size of tumor, proximity of tumor to line of resection, involvement of lymph nodes, and prophylactic radiation. The average age of the patients with recurrence was 7 years less than those without, and the incidence of nodal involvement was three times as high in those with local recurrence as in those without. These were the only factors that showed any significant difference between the two groups. When axillary dissection is done in patients treated by partial mastectomy, valuable information is obtained about the likelihood of local recurrence.

Entities:  

Mesh:

Year:  1990        PMID: 2157559     DOI: 10.3949/ccjm.57.2.143

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

1.  Treatment of breast cancer.

Authors:  R A Evans
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

2.  Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.

Authors:  Geoffrey S Ibbott; W F Hanson; Elizabeth O'Meara; Robert R Kuske; Douglas Arthur; Rachel Rabinovitch; Julia White; Raymond M Wilenzick; Irene Harris; Ramesh C Tailor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-01       Impact factor: 7.038

3.  Factors associated with local breast cancer recurrence after lumpectomy alone.

Authors:  D R McCready; W Hanna; H Kahn; J A Chapman; J Wall; E B Fish; H L Lickley
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.